Track Potassium Clavulanate Price Chart Historical and Forecast

Executive Summary

The global Potassium Clavulanate market experienced a notable downward trend through 2025, with sustained price softening observed across North America, Asia-Pacific, and Europe. Oversupply from major exporters, elevated inventories, cautious procurement, and logistical fluctuations shaped pricing dynamics across the quarters. In North America, U.S. prices fell sharply in Q3 2025, reflecting global destocking and reduced spot market activity. China and India continued to dominate the supply landscape in APAC, driving competitive pressure, while European markets contended with abundant inventories and import surges from Asia. Cost pressures and production trends were mixed, with some regions experiencing relief from lower energy and feedstock inputs and others facing upward drayage costs. Market forecasts suggest near-term softness with stabilization expected as inventories normalize and pharmaceutical buyers resume strategic restocking.

Introduction

Potassium Clavulanate remains a critical pharmaceutical intermediate, primarily used in combination with antibiotics to combat bacterial resistance. Its price trends are influenced by global production volumes, export flows, domestic procurement strategies, and macroeconomic factors such as currency fluctuations and tariffs. Across 2025, the market witnessed considerable volatility due to inventory gluts, aggressive discounting, and intermittent supply constraints. Understanding these dynamics is crucial for procurement teams, pharmaceutical formulators, and distributors seeking to optimize sourcing strategies.

◼ Get Instant Access to Live Potassium Clavulanate Prices Today: https://www.chemanalyst.com/Pricing-data/potassium-clavulanate-1652

Global Price Overview

The global Potassium Clavulanate market recorded consistent quarter-over-quarter declines in 2025. Prices peaked in Q1, driven by strong demand and supply disruptions, but gradually fell through Q2 and Q3 due to oversupply and muted procurement activity. Spot price behavior and indexed trends highlighted the influence of Chinese and Indian exports, logistics developments, and seasonal demand fluctuations. Production costs reflected varying energy, feedstock, and labor dynamics, contributing to region-specific pricing patterns.

Potassium Clavulanate Historical Price Overview (USD/MT)

| Quarter | North America (CFR Los Angeles) | APAC (FOB Shanghai) | Europe (CFR Hamburg) |

| Q4 2024 | 95,000 - 100,350 | 96,500 - 101,200 | 94,800 - 99,000 |
| Q1 2025 | 98,500 - 92,300 | 99,800 - 93,000 | 97,900 - 92,400 |
| Q2 2025 | 100,350 - 85,165 | 100,200 - 90,000 | 100,295 - 85,115 |
| Q3 2025 | 85,450 | 85,333 | 85,443 |

◼ Monitor Real-Time Potassium Clavulanate Price Swings and Stay Ahead of Competitors: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Potassium%20Clavulanate

Regional Analysis

North America

In the U.S., the Potassium Clavulanate Price Index declined by 10.27% in Q3 2025 compared to the previous quarter. The average price settled around USD 85,450 per metric ton, CFR Los Angeles. Spot prices softened as Asian exporters offered discounts to clear excess inventories, while pre-stocking by domestic manufacturers further suppressed new procurement.

Key Market Drivers

Aggressive export volumes from China and India contributed to inventory gluts.
Reduced demand due to cautious pharmaceutical procurement and tariff uncertainty.
Logistics improvements enabled limited recovery but could not offset overall downward pressure.
Production cost trends experienced mild upward pressure from higher drayage and transportation costs.
Historical Price Movement

Q2 2025 saw U.S. prices drop from approximately USD 100,350 in April to USD 90,170 in June, continuing to USD 85,165 by July. Q1 had a fluctuating start with price surges in January and February due to strong demand and constrained logistics, followed by a decline in March as inventories stabilized.

Procurement Behavior and Supply Conditions

Buyers drew down existing stocks, delaying spot purchases. Elevated inventories and cautious purchasing maintained a buyer-favorable market. Temporary plant turnarounds in Asia tightened supply intermittently, but overall competition and discounting drove pricing softness.

Asia-Pacific (APAC)

China led APAC price dynamics, with the Potassium Clavulanate Price Index falling by 10.24% quarter-over-quarter in Q3 2025. The average FOB Shanghai price was USD 85,333 per metric ton. Spot prices experienced temporary spikes due to logistical disruptions and maintenance-driven production slowdowns, yet overall pricing remained subdued.

Market Drivers and Dynamics

Oversupply from aggressive destocking and resumed output created downward pressure.
Logistics bottlenecks, port congestion, and temporary maintenance constraints caused short-term price volatility.
Domestic pharmaceutical procurement remained weak amid export restrictions and elevated inventory levels.
Production costs were moderated by lower raw material prices, compressing margins and limiting further price reductions.
Quarterly Review

Q2 2025 reflected a decline from approximately USD 100,200 in April to USD 90,000 in June. Q1 2025 began with strong upward momentum due to export demand, tariff-related anticipation, and low inventories, followed by moderation in March as competition and post-holiday corrections emerged.

◼ Track Daily Potassium Clavulanate Price Updates and Strengthen Your Procurement Decisions: https://www.chemanalyst.com/Pricing-data/potassium-clavulanate-1652

Supply, Demand, and Logistics

Supply overshang pressured prices despite occasional shortages from maintenance. Weak downstream procurement, export barriers, and high inventories prolonged the bearish trend. Freight disruptions temporarily tightened availability, causing spot volatility but not reversing the overall decline.

Europe

Germany, representing the European market, recorded a 10.22% quarter-over-quarter decline in Q3 2025. The average CFR Hamburg price stood at USD 85,443 per metric ton. Spot prices weakened as distributors cleared excess stock amid muted domestic procurement and euro appreciation.

Drivers of Price Movement

Abundant inventories and elevated imports from China maintained downward pressure.
Logistics issues, including shipping delays and port congestion, introduced volatility but did not materially support pricing.
Production costs eased with lower energy and feedstock inputs, sustaining competitive exporter pricing.
Demand remained steady among pharmaceutical formulators, hospitals, and outpatient units, supporting baseline consumption.
Historical Trends

In Q2 2025, prices decreased from USD 100,295 in April to USD 85,115 by July. Q1 saw a mixed trajectory with moderate increases in January and February due to supply constraints and logistics challenges, followed by a decline in March driven by improved supply and high domestic inventories. Q4 2024 included initial price decreases in Germany, offset by November and December increases due to import constraints and elevated demand.

Procurement and Trade Flow Insights

European buyers relied on cautious replenishment amid abundant inventories. Strong imports from Asia, combined with euro appreciation, accentuated downward pricing. Logistics bottlenecks occasionally affected supply margins but did not alter the overall bearish trend.

◼ Unlock Live Pricing Dashboards for Accurate and Timely Insights: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Potassium%20Clavulanate

Production and Cost Structure Insights

Global production costs exhibited region-specific trends, with U.S. markets facing upward pressure from transportation and drayage, APAC experiencing lower input costs, and Europe benefiting from reduced energy and feedstock expenses.
Maintenance-related shutdowns, raw material price fluctuations, and labor factors influenced short-term spot price spikes.
Despite localized cost pressures, global oversupply and inventory accumulation dominated market behavior, limiting the ability of production costs to drive pricing increases.
Procurement Outlook

North America and Europe are expected to stabilize as pharmaceutical buyers gradually restock inventories.
APAC pricing may see modest fluctuations due to ongoing domestic competition and selective restocking, although elevated supply levels and muted procurement are likely to maintain softness.
Tariff uncertainties, currency fluctuations, and logistics efficiency will continue influencing procurement timing and spot purchasing strategies.
FAQ

Why did Potassium Clavulanate prices decline in North America in Q3 2025

Aggressive export volumes from China and India created inventory surpluses. Domestic manufacturers had pre-stocked earlier, reducing immediate demand. Tariff uncertainty and logistics volatility delayed new orders, suppressing spot activity.

What caused price volatility in APAC markets

Oversupply from destocking and resumed output created downward pressure, while temporary logistical disruptions and maintenance shortages caused short-term upward spikes. Weak domestic procurement and export restrictions prolonged overall price weakness.

Why were European prices affected by currency movements

Euro appreciation increased the relative cost advantage of imports from China, amplifying downward pressure on local prices. Elevated inventory levels among German distributors also reduced transactional urgency, maintaining bearish pricing.

What is the near-term price outlook globally

Prices are expected to remain soft in the short term, with stabilization likely as inventories normalize and buyers resume strategic restocking. Supply chain constraints or a resurgence in pharmaceutical demand could influence trends.

How ChemAnalyst Supports Buyers

ChemAnalyst delivers real-time market intelligence, weekly price updates, and actionable insights for over 450 commodities, including Potassium Clavulanate. Beyond raw pricing data, ChemAnalyst explains the reasons behind price movements, highlights procurement opportunities, and tracks plant shutdowns to assess potential supply disruptions.

Its expert team of chemical engineers and market analysts provides a comprehensive view of global trade flows, costs, and logistics. Offices in Houston, Cologne, and New Delhi, along with teams at 50+ major trading ports, enable firsthand information gathering. Buyers benefit from reliable forecasts, supply chain intelligence, and strategic insights to optimize procurement timing, reduce costs, and mitigate risks.

Potassium Clavulanate pricing in 2025 reflects the balance between oversupply, logistics dynamics, and cautious procurement. Global markets remain sensitive to Asian exports, inventory cycles, and production cost pressures. Stakeholders equipped with accurate, real-time intelligence are better positioned to navigate volatility, stabilize sourcing, and make informed purchasing decisions.

◼ Stay Updated Each Day with Verified Potassium Clavulanate Price Movements: https://www.chemanalyst.com/Pricing-data/potassium-clavulanate-1652

Contact Us:

UNITED STATES

Call +1 3322586602

420 Lexington Avenue, Suite 300, New York, NY,

United States, 10170

Germany

Call +49-221-6505-8833

S-01, 2.floor, Subbelrather Straße,

15a Cologne, 50823, Germany

Email: sales@chemanalyst.com

LinkedIn: https://www.linkedin.com/company/chemanalyst/

Facebook: https://www.facebook.com/ChemAnalysts/

Twitter: https://x.com/chemanalysts

YouTube: https://www.youtube.com/@chemanalyst

Instagram: https://www.instagram.com/chemanalyst_

Website: https://www.chemanalyst.com/

About Us:

Welcome to ChemAnalyst, a next-generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as "Product Innovator of the Year 2023" and ranked among the "Top 100 Digital Procurement Solutions Companies," we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

This release was published on openPR.